Regenosca

Lausanne, CH · 1 known investors

Regenosca develops TissueSpan, an absorbable mesh implant that prompts the body to attract and organize its own cells for soft tissue regeneration, reinforcing or replacing damaged tissue. Its initial target application is urethral stricture repair, with potential use across a range of regenerative surgical interventions.